A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult Panelists
The purpose of this study is to evaluate the flavor (basic tastes, aroma, texture, mouthfeel) of VNZ/TEZ/D-IVA fixed dose combination (FDC) granules.
- EligibilityCriteria: Key Inclusion Criteria:  Panelists are trained to detect, identify, recognize, and accurately describe different taste elements and flavor combinations.  Key Exclusion Criteria:  History of any illness or clinical condition that, in the opinion of the investigator, might confound the results of the study or pose an additional risk to the participant. Sensitivity to VNZ, TEZ, or D-IVA. Pregnant, nursing, or planning to become pregnant during the study  Other protocol defined Inclusion/Exclusion criteria may apply. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 25 Years - MaximumAge: 80 Years - StdAgeList: Adult, Older Adult